Join
Live feed
·
INSIDERFilingvia Quantisnow
Theravance Biopharma Inc. logo

Director Broshy Eran sold $590,020 worth of Ordinary Shares (29,501 units at $20.00), decreasing direct ownership by 40% to 44,703 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TBPH· Theravance Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TBPH (Theravance Biopharma Inc.) and more on Quantisnow.